Interestingly, proteomics has played a lead role in mapping cancer signaling pathways and has successfully delineated the break point cluster region (BCR)-ABL1, extracellular signal-regulated kinase (ERK) pathways, and mechanistic target of rapamycin (mTOR) pathways [23]. Here, MTOR is linked to cancer.